Aavas Financiers Limited , a retail-focused affordable housing finance company, has announced a significant employee stock option grant across three of its equity-based incentive plans. The Nomination and Remuneration Committee of the company's Board of Directors approved the issuance of a total of 17,33,700 stock options to eligible employees on November 11, 2025.

Breakdown of Stock Option Grants

The stock options were distributed across three different schemes:

Vesting Schedules

The granted options come with varying vesting schedules:

• ESOP-2022 and ESOP-2025: These plans follow a five-year vesting schedule, with 20% of the granted options vesting each year on the anniversary of the grant date.
• PSOP-2024: This plan has a four-year vesting schedule, with 25% of the options vesting each year.

Exercise Periods

The exercise periods for the vested options are as follows:

• ESOP-2022 and PSOP-2024: Vested options can be exercised within four years from each vesting date.
• ESOP-2025: Vested options have a longer exercise period of five years from each vesting date.

Compliance and Regulatory Aspects

Aavas Financiers confirmed that all three schemes are in compliance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company has not disclosed the pricing formula for these options, stating it is "As defined in the respective Scheme."

Impact and Significance

Employee stock option plans are often used as a tool for aligning employee interests with those of the company and its shareholders. By granting a substantial number of stock options, Aavas Financiers is likely aiming to:

1. Enhance employee retention, particularly for key talent
2. Motivate staff to contribute to the company's long-term growth and profitability
3. Create a sense of ownership among employees

The differentiated structure of the three plans, particularly the inclusion of a performance-based plan (PSOP-2024), suggests a strategic approach to reward and incentivize various levels or categories of employees.

As of the grant date, no options have been exercised, and consequently, there has been no immediate impact on the company's share capital or earnings per share. The potential dilution effect will only materialize as employees exercise their options over the coming years, subject to vesting conditions and exercise decisions.

Aavas Financiers' stock option grant comes at a time when the company continues to expand its presence in the affordable housing finance sector. The substantial number of options granted may indicate the company's confidence in its growth trajectory and its commitment to retaining and motivating its workforce in a competitive market.

Investors and market analysts will likely monitor the uptake and exercise of these options over time, as it could provide insights into employee confidence and the alignment of interests between the company's staff and its shareholders.

Aavas Financiers Limited , a prominent housing finance company, has received shareholder approval for several key initiatives during its 15th Annual General Meeting (AGM) held on September 16, 2025. The company, which focuses on home loans and MSME financing for rural and semi-urban customers, has secured backing for significant financial and operational decisions.

NCD Issuance Approved

Shareholders have given the nod to raise up to ₹8,500.00 crore through the issuance of Non-Convertible Debentures (NCDs) on a private placement basis. This fundraising initiative is set to take place over the next year, concluding by September 15, 2026. The approval allows for the issuance of NCDs in one or more tranches, including subordinate debentures, bonds, and other debt securities.

New ESOP Plan Introduced

The AGM also saw the approval of the 'Aavas Financiers Limited – Equity Stock Option Plan 2025' (ESOP-2025). This new plan encompasses a total of 23,74,191 exercisable options, each representing one equity share with a face value of ₹10.00.

Board Composition and Remuneration Changes

Several changes to the company's board composition were approved:

• Appointment of five Non-Executive Nominee Directors for five-year terms:

  1. Mr. Elcid Vergara
  2. Mr. Anant Jain
  3. Mr. Nikhil Omprakash Gahrotra
  4. Mrs. Neha Sureka
  5. Mr. Siddharth Tapaswin Patel

• Revision in the remuneration of Mr. Sachinderpalsingh Jitendrasingh Bhinder, Managing Director & Chief Executive Officer

Other Key Approvals

• Appointment of M/s. Chandrasekaran Associates as Secretarial Auditors for a five-year term from FY 2025-26 to FY 2029-30
• Increase in borrowing powers under Section 180(1)(c) of the Companies Act, 2013
• Creation of charges on company assets to secure borrowings under Section 180(1)(a) of the Companies Act, 2013

Market Performance

As of the latest available information, Aavas Financiers' shares closed at ₹1,649.40, reflecting a 11.30% decline over a six-month period.

These strategic decisions aim to strengthen Aavas Financiers' financial position and operational capabilities as it continues to serve its target market in rural and semi-urban areas of India.